201. Developments in Diagnostics and Treatment for Tuberculosis
Saturday, October 5, 2013: 2:00 PM-3:30 PM
Room: The Moscone Center: 130-131 (Hall E)
Co-organized with the Center for Global Health Policy

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the latest advances in new and recently approved drugs for treatment of tuberculosis
  • identify new approaches to treating complex tuberculosis cases
  • describe novel tools to diagnose tuberculosis and how to use them in clinical practice

Target Audience: researchers, public health practitioners, members-in-training, investigators, infectious diseases physicians, infectious diseases pediatricians, HIV specialists, HIV clinicians, fellows, clinicians

Tracks: HIV-STD-TB, Global ID

Moderator:  Constance Benson, MD, FIDSA, University of California


2:00 PM
New TB Drugs in Development
Richard Chaisson, MD, FIDSA

3:00 PM

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-102-L01-P


C. Benson, None

R. Chaisson, Merck: Shareholder, Stock dividends
Vertex: Consultant, Consulting fee

M. Shah, None

A. Luetkemeyer, Cepheid : Investigator, Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.